Subhash Chander
All India Institute of Medical Sciences
35 Papers
124 Citations
Subhash Chander is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 9, co-authored 35 publications.
Chat about Author
Papers
Radiation induced liver disease: A clinical update.
TL;DR: This review article has focussed on patho-physiology, risk factors, prevention and management of radiation-induced liver disease.
103
Neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.
Rajkumar Bikramjit Singh,Subhash Chander,Bidhu Kalyan Mohanti,Sushmita Pathy,Sunesh Kumar,Neerja Bhatla,Sanjay Thulkar,Sreenivas Vishnubhatla,Lalit Kumar +8 more
TL;DR: Neoadjuvant chemotherapy with dose dense weekly paclitaxel and carboplatin followed by standard CCRT is a feasible approach and is associated with a high response rate in locally advanced cervical cancer.
53
Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: A preliminary experience
TL;DR: High‐dose rate mode of TSEI is a technological innovation attached to a Linear Accelerator, which can deliver an electron beam of 30 Gy/min at the iso‐center of the linear accelerator, making the treatment execution much easier and patient compliance much better.
26
Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies
Lalit Kumar,R. Grover,Y. H. Pokharel,Subhash Chander,Sunesh Kumar,Rajesh Kumar Singh,G.K. Rath,Vinod Kochupillai +7 more
TL;DR: Three studies have failed to demonstrate any significant difference in overall and disease-free survival when neoadjuvant CT is added prior to the standard RT regimen, and response to CT predicts response to RT.
26
Cervical carcinoma recurring in an abdominal wall incision.
TL;DR: Two patients who developed recurrence in the abdominal wall incision after hysterectomy who had FIGO Stage IB1 cervical carcinoma are reported.
20